Navigation Links
Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
Date:10/24/2008

PARIS, October 24 /PRNewswire/ -- Novexel, a speciality pharmaceutical company focused on the discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance, announces that its pipeline will be the subject of five posters at the joint annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (48th annual ICAAC/IDSA 46th annual meeting), which takes place in Washington, DC, October 25-28, 2008.

NXL104, Novexel's broad spectrum class A and C ss-lactamase inhibitor, will be the subject of three posters. In vitro data will be presented showing that a ceftazidime/NXL104 combination is rapidly bactericidal against a range of beta-lactamase-producing Enterobacteriaceae and that one of the most important factors affecting the pharmacodynamics of the combination is maintaining a critical concentration of the inhibitor (NXL104) that suppresses beta-lactamase activity. (Poster A-023). A second poster describes the use of a ceftazidime/NXL104 disk diffusion assay for the detection and identification of the Klebsiella pneumoniae carbapenemase enzyme (KPC) in Enterobacteriaceae (Poster D-291b). The third poster details a microbroth dilution quality control study on ceftazidime/NXL104 (Poster F-2665).

The potent in vitro activity of NXL103, a novel oral streptogramin, will be presented against a range of staphylococci, including vancomycin intermediate and resistant isolates (Poster F1-365).

A fifth poster covers the anti-staphylococcal activity of NXL101, a bacterial gyrase inhibitor, now discontinued.

All posters will be available for download from Novexel's web site (http://www.novexel.com) shortly after the close of ICAAC.

About Novexel

Novexel is a speciality pharmaceutical company focused on the discovery and development of novel antibiotics de
'/>"/>

SOURCE Novexel
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
2. Mpex Pharmaceuticals Presents New Data on MP-376 in Cystic Fibrosis
3. Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora
4. Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium
5. Thermogard XP(TM) Studies to Be Presented at American Society of Anesthesiologists Annual Meeting
6. Trius Antibiotics to be Highlighted in 18 Presentations at ICAAC/IDSA
7. Cytopia Scientific Presentations on JAK2 Inhibitor Program
8. Paratek to Present Clinical Data in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
9. XTENT Announces Clinical Trial Data to be Presented at Annual Meeting of Transcatheter Cardiovascular Therapeutics Next Week
10. Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress
11. Prometheus Presents Findings From Development of PROMETHEUS(R) IBS Diagnostic, First Blood Test for IBS, at ACG Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Oregon, December 15 Bend Research Inc. announced,today ... file for HPMCAS, an,excipient used in technologies developed by ... drugs. , Bend Research clients ... (DMF),for HPMCAS for regulatory filings with the FDA, Bend ... excited about this new development and know it will ...
(Date:12/14/2009)... MALVERN, Pa., Dec. 14 Fujirebio Diagnostics ... Sciences Company of the Year by the Eastern ... the Hilton Hotel in Philadelphia on Thursday, December ... Council is the Philadelphia region,s largest technology and ... Awards" of the Technology and Life Sciences Community, ...
(Date:12/14/2009)... VIEW, Calif., Dec. 14 Alexza Pharmaceuticals, Inc. ... submitted its New Drug Application (NDA) for Staccato® loxapine ... AZ-004 is an inhalation product candidate being developed ... schizophrenia or bipolar disorder. The IND for ... August 2005. ,, "AZ-004 has delivered a predictable and ...
Breaking Medicine Technology:Bend Research Clients May Now Reference Key Safety Document for Important Solubility Excipient 2Fujirebio Diagnostics Named Life Sciences Company of the Year 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6U of I scientist 3A Public policy should promote family mealtimes 9845 1U of I scientist 3A Public policy should promote family mealtimes 9845 2U of I scientist 3A Public policy should promote family mealtimes 9845 3Nationwide Health Data Exchange Allows Health Provider Payers to Cooperate in Decreasing Waste and Helping Policyholder Costs 56610 1Nationwide Health Data Exchange Allows Health Provider Payers to Cooperate in Decreasing Waste and Helping Policyholder Costs 56610 2Day Care May Not Shield Kids From Asthma Allergies 56605 1Day Care May Not Shield Kids From Asthma Allergies 56605 2Day Care May Not Shield Kids From Asthma Allergies 56605 3
... Nov. 9 NTM Info & Research ... research for,nontuberculous mycobacterial (NTM) lung disease announces ... an innovative,program to provide guidance about pressing ... and clinical and treatment issues.,Small pilot studies ...
... WASHINGTON, Nov. 9 The Community Oncology,Alliance ... that the Centers for Medicare & Medicaid ... access of senior cancer patients to,vital anemia-fighting ... a,National Coverage Determination (NCD) limiting oncologists, use ...
Other Medicine Technology:Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions 2
(Date:12/15/2009)... Seattle, WA) – Delicious Planet, Seattle’s premier organic meal delivery ... launch of its Delicious Planet Detox Program, Randi Carter, company ... ... (December 15, 2009 – Seattle, WA) – Delicious ... is accepting orders now for the launch of its Delicious ...
(Date:12/15/2009)... PALM CITY, Fla., Dec. 15 Connectyx ... today that it has moved to a higher ... Current Information). The higher move positions Connectyx ... available. http://www.pinksheets.com/content/doc/ps/Disclosure/Guidelines/2.pdf ,, Connectyx President Ronn ... move as part of our efforts to become ...
(Date:12/15/2009)... Comcast Corporation and Stand Up To Cancer (SU2C) have ... Stand Up 2 Cancer On Demand to ... research. Debuting exclusively on Comcast beginning December 15th, ... feature an extraordinary library of musical entertainment including hundreds ... stars and groups. ,, Available for no ...
(Date:12/15/2009)... and SUNNYVALE, Calif., Dec. 15 ... Information Technology and Managed Services, and Ruckus ... (WLAN) solutions provider, today announce their partnership ... interference avoidance technology. ,, The collaboration will ... with Ruckus, cutting-edge Wi-Fi solutions, including its ...
(Date:12/15/2009)... At a time when Americans spend over $50 billion ... Raymond Hall is theorizing a painful connection between conventional ... called Pillo1 ( www.pillo1.com ) to address the problem. ... John,s Medical Plaza Sleep Disorders Center showed that Pillo1 ... position and promotes increased time spent in REM (rapid ...
Breaking Medicine News(10 mins):Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 2Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 3Health News:Delicious Planet Organic Meal Service Is Accepting Orders For Its Weekly Detox Program Delivery 4Health News:Connectyx Attains 'Current Listing' Status on Pink Sheets Exchange 2Health News:Connectyx Attains 'Current Listing' Status on Pink Sheets Exchange 3Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 2Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 3Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 4Health News:Comcast and Stand Up To Cancer Launch First-Ever Video-on-Demand Effort to Broaden Awareness and Raise Funds for Cancer Research 5Health News:Atrion Networking Corporation Selects Ruckus Wireless for 'Reliable as Wire' Enterprise Wi-Fi Service 2Health News:Atrion Networking Corporation Selects Ruckus Wireless for 'Reliable as Wire' Enterprise Wi-Fi Service 3Health News:Sleep Study Shows Pillo1 Re-Educates Body to Naturally Move Into Optimal Sleep Position and Increases REM Sleep by 21.3% 2
... is believed that the rate of clot formation inside a ... a days, the majority of angioplasties involve placement of a stent ... it open. But the very act of placing a stent in ... a clot - ironically, the actual problem which the procedure is ...
... Two of the leading pharmaceutical industries, Ranbaxy Laboratories ... once-a-day formulation of Ciprofloxacin. The formulation had recently ... for marketing in India. Ciproloxacin is a unique ... market for ciprofloxacin is estimated to be around ...
... may help to protect the liver from damage, according ... 22 other fruits to laboratory rats. The rats were ... by interfering with cell synthesis and results in cell ... amount of liver damage.// ,The Researchers discovered three ...
... is known for its adverse effects on the heart ... called PM10s, which have a diameter of less than ... heart function, by entering the circulation, especially in people ... study by researchers at Harvard University now reveals that ...
... acupuncture is at least as safe as conventional medicine.,There ... of complementary and alternative medicine(CAM). , ,According to ... safety assessments on acupuncture. In the first, 78 doctors ... adverse events occurring between June 1998 and February 2000. ...
... school of Medicine from Harvard,after studying the eating behavior and the ... animal fats and less vegetables in the diet between the 6th ... the research to an early puberty. ,The results of the ... and to maintain a healthy weight throughout all life.// Because in ...
Other Medicine News:
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: